Cipla Limited has informed the Exchange regarding a press release dated May 10, 2024, titled "Q4 & FY24 results".
Press Release May 10 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Cipla
- Press Release Mar 26 2024
- Press Release Jan 22 2024
- Press Release Jan 08 2024
- Press Release (Revised) Dec 15 2023
- Press Release Dec 14 2023
Later from Cipla
- Cipla announces additional investment in Achira
- Press Release Jun 18 2024
- Cipla EU to invest an additional EUR 3 million in Ethris
- Cipla signs a non-exclusive patent license agreement with Takeda to commercialize Vonoprazan drug in India
- Cipla: Orchid Pharma partners with Cipla to launch antibiotic Cefepime - Enmetazobactam in India
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla